전임상 CRO 서비스 시장 : 기회 및 전략(-2035년)

Preclinical contract research organization (CRO) services are outsourced research services that support the early-stage development of drugs, biologics, and medical devices before human clinical trials begin. The primary purpose of preclinical CRO services is to generate reliable scientific and safety data required for regulatory approval to proceed into clinical trials. They help pharmaceutical and biotechnology companies reduce development risk, control costs, accelerate timelines, and ensure compliance.

The preclinical CRO services market consists of sales, by entities (organizations, sole traders, or partnerships) of services that are predominantly used by pharmaceutical companies, biotechnology firms, academic research institutions, and medical device manufacturers to evaluate the safety, efficacy, pharmacokinetics, and pharmacodynamics of candidate compounds. The services are typically utilized during the investigational new drug (IND)-enabling phase of a compound's lifecycle, which occurs after initial target identification and lead optimization, but before first-in-human clinical studies.

The global preclinical CRO services market was valued at $3,726.2 million in 2020 which grew till 2025 at a compound annual growth rate (CAGR) of more than 10.00%.

Expansion Of Clinical Trials And Robust Therapeutic Pipeline

The expansion of clinical trials and robust therapeutic pipelines supported the growth of the preclinical CRO services market in the historic period. An increasing number of drug candidates across small molecules, biologics and advanced therapies progressed from discovery to clinical evaluation, driving strong demand for preclinical studies. Sponsors were required to conduct comprehensive pharmacology, toxicology and safety assessments before initiating human trials, which increased reliance on specialized CRO services. Additionally, the rise in global clinical trial activity encouraged pharmaceutical and biotechnology companies to outsource preclinical work to accelerate development timelines and manage costs. For instance, in December 2024, according to the Association of the British Pharmaceutical Industry (ABPI), a UK-based organization, reported that the total number of clinical trials initiated in the UK rose from 411 in 2022 to 426 in 2023. Therefore, the expansion of clinical trials and robust therapeutic pipeline drove the growth of the preclinical CRO services market.

AI-Enabled Human-Relevant Preclinical Collaboration Advancing Predictive Research Models

Key companies operating in the preclinical CRO services market are focusing on forming strategic partnerships and integrating AI-enabled, human-relevant research technologies to enhance data quality, improve predictive accuracy and accelerate drug discovery and safety assessment processes. For instance, in January 2026, Xellar Biosystems, a US-based Biotechnology research company, partnered with WOOJUNG BIO, a South Korea-based research institute to advance artificial intelligence (AI)-enabled, human-relevant preclinical research platforms. The collaboration combines Xellar's organ-on-a-chip technology, computer-vision analytics and artificial intelligence (AI)-driven data capabilities with WOOJUNG BIO's strong expertise in translational research and life-science services. Together, the companies aim to develop integrated hybrid in vitro-animal preclinical workflows that improve research efficiency, data quality and reproducibility. The partnership reflects a growing industry shift toward more predictive, human-relevant models in drug discovery and safety testing, while strengthening both companies' positions in next-generation preclinical research solutions.

The global preclinical CRO services market is fairly concentrated, with large players operating in the market. The top 10 competitors in the market made up 28.46% of the total market in 2024.

Preclinical CRO Services Global Market Opportunities And Strategies To 2035 from The Business Research Company provides the strategists; marketers and senior management with the critical information they need to assess the global preclinical CRO services market as it emerges from the COVID-19 shut down.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 13 geographies.
• Understand how the market is being affected by the coronavirus and how it is likely to emerge and grow as the impact of the virus abates.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market research findings.
• Benchmark performance against key competitors.
• Utilize the relationships between key data sets for superior strategizing.
• Suitable for supporting your internal and external presentations with reliable high-quality data and analysis.

Where is the largest and fastest-growing market for preclinical CRO services? How does the market relate to the overall economy; demography and other similar markets? What forces will shape the market going forward? The preclinical CRO services market global report from The Business Research Company answers all these questions and many more.

The report covers market characteristics; size and growth; segmentation; regional and country breakdowns; competitive landscape; market shares; trends and strategies for this market. It traces the market's history and forecasts market growth by geography. It places the market within the context of the wider preclinical CRO services market; and compares it with other markets.

The report covers the following chapters

• Introduction and Market Characteristics- Brief introduction to the segmentations covered in the market, definitions and explanations about the segment by service type, by animal model, by assay type and by disease area
• Key Trends- Highlights the major trends shaping the global market. This section also highlights likely future developments in the market.
• Growth Analysis And Strategic Analysis Framework Analysis on PESTEL, end use industries, market growth rate, global historic (2020-2025) and forecast (2025-2030, 2035F) market values and drivers and restraints that support and control the growth of the market in the historic and forecast periods, forecast growth contributors and total addressable market (TAM).
• Global Market Size And Growth Global historic (2020-2025) and forecast (2025-2030, 2035F) market values and drivers and restraints that support and control the growth of the market in the historic and forecast periods.
• Regional And Country Analysis- Historic (2020-2025) and forecast (2025-2030, 2035F) market values and growth and market share comparison by region and country.
• Market Segmentation- Contains the market values (2020-2025) (2025-2030, 2035F) and analysis for each segment by service type, by animal model, by assay type and by disease area in the market. Historic (2020-2025) and forecast (2025-2030) and (2030-2035) market values and growth and market share comparison by region market.
• Regional Market Size and Growth- Regional market size (2025), historic (2020-2025) and forecast (2025-2030, 2035F) market values and growth and market share comparison of countries within the region. This report includes information on all the regions Asia-Pacific, Europe and Rest of the World (ROW).
• Competitive Landscape- Details on the competitive landscape of the market, estimated market shares and company profiles of the leading players.
• Other Major And Innovative Companies Details on the company profiles of other major and innovative companies in the market.
• Competitive Benchmarking- Briefs on the financials comparison between major players in the market.
• Competitive Dashboard- Briefs on competitive dashboard of major players.
• Key Mergers and Acquisitions- Information on recent mergers and acquisitions in the market is covered in the report. This section gives key financial details of mergers and acquisitions which have shaped the market in recent years.
• Recent Developments Information on recent developments in the market covered in the report.
• Market Opportunities And Strategies Describes market opportunities and strategies based on findings of the research, with information on growth opportunities across countries, segments and strategies to be followed in those markets.
• Conclusions And Recommendations- This section includes recommendations for preclinical CRO services providers in terms of product/service offerings geographic expansion, marketing strategies and target groups.
• Appendix- This section includes details on the NAICS codes covered, abbreviations and currencies codes used in this report.

Markets Covered:

• 1) By Service Type: Target Validation And Screening; Drug Discovery And Drug ID; Preclinical Pharmacology; Toxicology And Safety Assessment; PK/ADME Studies; Biomarker Development; Other Key Service Stages
• 2) By Animal Model: Small Animal Model; Large Animal Model
• 3) By Assay Type: In-Vitro Bioassay; In-Vivo Efficacy Assay; Pharmacokinetic (PK) Assay; ADME Assay; Toxicology Assay; Other Assay Types
• 4) By Disease Area: Oncology; Central Nervous System (CNS) Disorders; Cardiovascular Diseases; Metabolic Disorders; Infectious Diseases; Autoimmune And Inflammatory Diseases; Other Disease Areas
• Companies Mentioned:Charles River Laboratories; Wuxi AppTec Co. Ltd.; Eurofins Scientific SE; Pharmaron Beijing Co Ltd.; Aragen Life Sciences
• Countries: China; Australia; India; Indonesia; Japan; South Korea; USA; Germany; Italy; Spain; UK; France; Russia
• Regions: Asia-Pacific; Europe; Rest Of The World
• Time-series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets; GDP proportions; expenditure per capita; hostels indicators comparison.
• Data segmentations: country and regional historic and forecast data; market share of competitors; market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

Table of Contents

1 Executive Summary

• 1.1 Preclinical CRO Services - Market Attractiveness And Macro Economic Landscape

2 Table Of Contents

3 List Of Tables

4 List Of Figures

5 Report Structure

6 Market Characteristics

• 6.1 General Market Definition
• 6.2 Summary
• 6.3 Preclinical CRO Services Market Definition And Segmentations
• 6.4 Market Segmentation By Service Type
  • 6.4.1 Target Validation and Screening
  • 6.4.2 Drug Discovery and Drug Identification
  • 6.4.3 Preclinical Pharmacology
  • 6.4.4 Toxicology and Safety Assessment
  • 6.4.5 PK/ADME Studies
  • 6.4.6 Biomarker Development
  • 6.4.7 Other Key Service Stages
• 6.5 Market Segmentation By Animal Model
  • 6.5.1 Small Animal Model
  • 6.5.2 Large Animal Model
• 6.6 Market Segmentation By Assay Type
  • 6.6.1 In-Vitro Bioassay
  • 6.6.2 In-Vivo Efficacy Assay
  • 6.6.3 Pharmacokinetic (PK) Assay
  • 6.6.4 ADME Assay
  • 6.6.5 Toxicology Assay
  • 6.6.6 Other Assay Types
• 6.7 Market Segmentation By Disease Area
  • 6.7.1 Oncology
  • 6.7.2 CNS Disorders
  • 6.7.3 Cardiovascular Diseases
  • 6.7.4 Metabolic Disorders
  • 6.7.5 Infectious Diseases
  • 6.7.6 Autoimmune and Inflammatory Diseases
  • 6.7.7 Other Disease Areas

7 Information On Opportunities And Threats In The Preclinical CRO Services Market

• 7.1 Opportunities in the Global Preclinical CRO Services Landscape
  • 7.1.1 Rising Outsourcing of Preclinical Research
  • 7.1.2 Expansion of Biopharmaceuticals and Advanced Therapies
  • 7.1.3 Technological Advancements in Preclinical Models
  • 7.1.4 Growth Opportunities in Emerging Markets
  • 7.1.5 Increasing Demand for Integrated and End-to-End Services
• 7.2 Threats in the Global Preclinical CRO Services Landscape
  • 7.2.1 Complex and Evolving Regulatory Requirements
  • 7.2.2 Ethical Concerns and Restrictions on Animal Testing
  • 7.2.3 Intensifying Competitive Pressure
  • 7.2.4 Data Security and Intellectual Property Risks
  • 7.2.5 Partial Insourcing by Pharmaceutical Companies

8 Information on Challenges And Value Creation Levers In the Preclinical CRO Services market at global level

• 8.1 Challenges In Preclinical CRO Services market
  • 8.1.1 Stringent and Heterogeneous Regulatory Landscape
  • 8.1.2 High Operational Costs and Infrastructure Requirements
  • 8.1.3 Talent Scarcity and Skills Gap
  • 8.1.4 Heightened Ethical and Societal Pressure Around Animal Testing
  • 8.1.5 Competitive Pressures and Market Fragmentation
  • 8.1.6 Data Management, Standardization, and Security Challenges
  • 8.1.7 Translational Validity and Scientific Challenges
  • 8.1.8 Client Preferences and Internalization Trends
  • 8.1.9 High Capital and Operational Costs
  • 8.1.10 Shortage of Skilled Scientific Talent
• 8.2 Value Creation Levers in the Preclinical CRO Services Market
• 8.3 Pricing Optimization
• 8.4 Customer Expansion
• 8.5 Market Penetration
• 8.6 Market Expansion
• 8.7 Product Expansion

9 The CRO Preclinical Services Market, Insights On Cell-Based Assays, With Emphasis On New Approach Methodologies (NAMs)

• 9.1 Mechanism-Based and Pathway-Focused Assays
• 9.2 High-Throughput and High-Content Screening (HTS/HCS)
• 9.3 3D Cell Models and Organoids
• 9.4 Microphysiological Systems (Organ-on-Chip)
• 9.5 Stem Cell-Based and iPSC-Derived Assays

10 List Of Most Profitable Preclinical CRO Assay Services By Rank At Global Level

11 Major Market Trends

• 11.1 AI-Enabled Human-Relevant Preclinical Collaboration Advancing Predictive Research Models
• 11.2 Expansion Into Advanced Human-Relevant Preclinical Models For Precision Drug Screening
• 11.3 High-Throughput Ion Channel Assay Development Accelerating Non-Opioid Pain Drug Discovery
• 11.4 Strategic Expansion Into Comprehensive Oncology Preclinical Research Services
• 11.5 Strategic Partnerships Enhancing High-Throughput Screening For Efficient Drug Discovery

12 Global Preclinical CRO Services Growth Analysis And Strategic Analysis Framework

• 12.1 Global PESTEL Analysis
  • 12.1.1 Political
  • 12.1.2 Economic
  • 12.1.3 Social
  • 12.1.4 Technological
  • 12.1.5 Environmental
  • 12.1.6 Legal
• 12.2 Analysis Of End Users (B2C)
  • 12.2.1 Pharmaceutical And Biotechnology Companies
  • 12.2.2 Academic And Research Institutes
  • 12.2.3 Government And Public Health Research Organizations
  • 12.2.4 Virtual And Asset-Light Drug Developers
  • 12.2.5 Other End Users
• 12.3 Global Preclinical CRO Services Market Growth Rate Analysis
• 12.4 Historic Market Growth, 2020 - 2025, Value ($ Million)
  • 12.4.1 Market Drivers 2020 - 2025
  • 12.4.2 Market Restraints 2020 - 2025
• 12.5 Forecast Market Growth, 2025 - 2030, 2035F Value ($ Million)
• 12.6 Forecast Growth Contributors/Factors
  • 12.6.1 Quantitative Growth Contributors
  • 12.6.2 Drivers
  • 12.6.3 Restraints
• 12.7 Total Addressable Market for the Preclinical CRO Services Market - Business to Customer (B2C)
  • 12.7.1 TAM Comparison Analysis

13 Global Preclinical CRO Services Market Segmentation

• 13.1 Global Preclinical CRO Services Market, Segmentation By Service Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
• 13.2 Global Preclinical CRO Services Market, Segmentation By Animal Model, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
• 13.3 Global Preclinical CRO Services Market, Segmentation By Assay Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
• 13.4 Global Preclinical CRO Services Market, Segmentation By Disease Area, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)

14 Preclinical CRO Services Market, Regional and Country Analysis

• 14.1 Global Preclinical CRO Services Market, By Region, Historic and Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
• 14.2 Global Preclinical CRO Services Market, By Country, Historic and Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)

15 Asia-Pacific Market

• 15.1 Market Overview
  • 15.1.1 Region Information
  • 15.1.2 Market Information
  • 15.1.3 Background Information
  • 15.1.4 Government Initiatives
  • 15.1.5 Regulations
  • 15.1.6 Regulatory Bodies
  • 15.1.7 Major Associations
  • 15.1.8 Taxes Levied
  • 15.1.9 Corporate Tax Structure
  • 15.1.10 Investments
  • 15.1.11 Major Companies
• 15.2 Asia-Pacific Preclinical CRO Services Market, Segmentation By Service Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
• 15.3 Asia-Pacific Preclinical CRO Services Market, Segmentation By Animal Model, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
• 15.4 Asia-Pacific Preclinical CRO Services Market, Segmentation By Assay Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
• 15.5 Asia-Pacific Preclinical CRO Services Market, Segmentation By Disease Area, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
• 15.6 Asia-Pacific Preclinical CRO Services Market: Country Analysis
• 15.7 China Market
• 15.8 Market Overview
  • 15.8.1 Country Information
  • 15.8.2 Market Information
  • 15.8.3 Background Information
  • 15.8.4 Government Initiatives
  • 15.8.5 Regulations
  • 15.8.6 Regulatory Bodies
  • 15.8.7 Major Associations
  • 15.8.8 Taxes Levied
  • 15.8.9 Corporate Tax Structure
  • 15.8.10 Investments
  • 15.8.11 Major Companies
• 15.9 China Preclinical CRO Services Market, Segmentation By Service Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
• 15.10 China Preclinical CRO Services Market, Segmentation By Animal Model, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
• 15.11 China Preclinical CRO Services Market, Segmentation By Assay Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
• 15.12 China Preclinical CRO Services Market, Segmentation By Disease Area, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
• 15.13 India Market
• 15.14 India Preclinical CRO Services Market, Segmentation By Service Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
• 15.15 India Preclinical CRO Services Market, Segmentation By Animal Model, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
• 15.16 India Preclinical CRO Services Market, Segmentation By Assay Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
• 15.17 India Preclinical CRO Services Market, Segmentation By Disease Area, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
• 15.18 Japan Market
• 15.19 Market Overview
  • 15.19.1 Country Information
  • 15.19.2 Market Information
  • 15.19.3 Background Information
  • 15.19.4 Government Initiatives
  • 15.19.5 Regulations
  • 15.19.6 Regulatory Bodies
  • 15.19.7 Major Associations
  • 15.19.8 Taxes Levied
  • 15.19.9 Corporate Tax Structure
  • 15.19.10 Investments
  • 15.19.11 Major Companies
• 15.20 Japan Preclinical CRO Services Market, Segmentation By Service Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
• 15.21 Japan Preclinical CRO Services Market, Segmentation By Animal Model, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
• 15.22 Japan Preclinical CRO Services Market, Segmentation By Assay Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
• 15.23 Japan Preclinical CRO Services Market, Segmentation By Disease Area, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
• 15.24 South Korea Market
• 15.25 Market Overview
  • 15.25.1 Country Information
  • 15.25.2 Market Information
  • 15.25.3 Background Information
  • 15.25.4 Government Initiatives
  • 15.25.5 Regulations
  • 15.25.6 Regulatory Bodies
  • 15.25.7 Major Associations
  • 15.25.8 Taxes Levied
  • 15.25.9 Corporate Tax Structure
  • 15.25.10 Major Companies
• 15.26 South Korea Preclinical CRO Services Market, Segmentation By Service Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
• 15.27 South Korea Preclinical CRO Services Market, Segmentation By Animal Model, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
• 15.28 South Korea Preclinical CRO Services Market, Segmentation By Assay Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
• 15.29 South Korea Preclinical CRO Services Market, Segmentation By Disease Area, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
• 15.30 Australia Market
• 15.31 Australia Preclinical CRO Services Market, Segmentation By Service Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
• 15.32 Australia Preclinical CRO Services Market, Segmentation By Animal Model, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
• 15.33 Australia Preclinical CRO Services Market, Segmentation By Assay Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
• 15.34 Australia Preclinical CRO Services Market, Segmentation By Disease Area, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
• 15.35 Indonesia Market
• 15.36 Indonesia Preclinical CRO Services Market, Segmentation By Service Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
• 15.37 Indonesia Preclinical CRO Services Market, Segmentation By Animal Model, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
• 15.38 Indonesia Preclinical CRO Services Market, Segmentation By Assay Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
• 15.39 Indonesia Preclinical CRO Services Market, Segmentation By Disease Area, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)

16 Europe Market

• 16.1 Market Overview
  • 16.1.1 Region Information
  • 16.1.2 Market Information
  • 16.1.3 Background Information
  • 16.1.4 Government Initiatives
  • 16.1.5 Regulations
  • 16.1.6 Regulatory Bodies
  • 16.1.7 Major Associations
  • 16.1.8 Taxes Levied
  • 16.1.9 Corporate tax structure
  • 16.1.10 Investments
  • 16.1.11 Major Companies
• 16.2 Europe Preclinical CRO Services Market, Segmentation By Service Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
• 16.3 Europe Preclinical CRO Services Market, Segmentation By Animal Model, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
• 16.4 Europe Preclinical CRO Services Market, Segmentation By Assay Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
• 16.5 Europe Preclinical CRO Services Market, Segmentation By Disease Area, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
• 16.6 UK Market
• 16.7 UK Preclinical CRO Services Market, Segmentation By Service Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
• 16.8 UK Preclinical CRO Services Market, Segmentation By Animal Model, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
• 16.9 UK Preclinical CRO Services Market, Segmentation By Assay Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
• 16.10 UK Preclinical CRO Services Market, Segmentation By Disease Area, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
• 16.11 Germany Market
• 16.12 Germany Preclinical CRO Services Market, Segmentation By Service Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
• 16.13 Germany Preclinical CRO Services Market, Segmentation By Animal Model, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
• 16.14 Germany Preclinical CRO Services Market, Segmentation By Assay Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
• 16.15 Germany Preclinical CRO Services Market, Segmentation By Disease Area, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
• 16.16 France Market
• 16.17 France Preclinical CRO Services Market, Segmentation By Service Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
• 16.18 France Preclinical CRO Services Market, Segmentation By Animal Model, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
• 16.19 France Preclinical CRO Services Market, Segmentation By Assay Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
• 16.20 France Preclinical CRO Services Market, Segmentation By Disease Area, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
• 16.21 Italy Market
• 16.22 Italy Preclinical CRO Services Market, Segmentation By Service Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
• 16.23 Italy Preclinical CRO Services Market, Segmentation By Animal Model, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
• 16.24 Italy Preclinical CRO Services Market, Segmentation By Assay Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
• 16.25 Italy Preclinical CRO Services Market, Segmentation By Disease Area, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
• 16.26 Spain Market
• 16.27 Spain Preclinical CRO Services Market, Segmentation By Service Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
• 16.28 Spain Preclinical CRO Services Market, Segmentation By Animal Model, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
• 16.29 Spain Preclinical CRO Services Market, Segmentation By Assay Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
• 16.30 Spain Preclinical CRO Services Market, Segmentation By Disease Area, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
• 16.31 Russia Market
• 16.32 Russia Preclinical CRO Services Market, Segmentation By Service Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
• 16.33 Russia Preclinical CRO Services Market, Segmentation By Animal Model, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
• 16.34 Russia Preclinical CRO Services Market, Segmentation By Assay Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
• 16.35 Russia Preclinical CRO Services Market, Segmentation By Disease Area, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
• 16.36 USA Market
• 16.37 Market Overview
  • 16.37.1 Country Information
  • 16.37.2 Market Information
  • 16.37.3 Background Information
  • 16.37.4 Government Initiatives
  • 16.37.5 Regulations
  • 16.37.6 Regulatory Bodies
  • 16.37.7 Major Associations
  • 16.37.8 Taxes Levied
  • 16.37.9 Corporate Tax Structure
  • 16.37.10 Investments
  • 16.37.11 Major Companies
• 16.38 USA Preclinical CRO Services Market, Segmentation By Service Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
• 16.39 USA Preclinical CRO Services Market, Segmentation By Animal Model, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
• 16.40 USA Preclinical CRO Services Market, Segmentation By Assay Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
• 16.41 USA Preclinical CRO Services Market, Segmentation By Disease Area, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)

17 Rest of the World (ROW) Market

• 17.1 Market Overview
  • 17.1.4 Region Information
  • 17.1.5 Market Information
  • 17.1.6 Background Information
  • 17.1.7 Government Initiatives
  • 17.1.8 Regulations
  • 17.1.9 Regulatory Bodies
  • 17.1.10 Major Associations
  • 17.1.11 Taxes Levied
  • 17.1.12 Corporate Tax Structure
  • 17.1.13 Major Companies
• 17.2 Rest of the World (ROW) Preclinical CRO Services Market, Segmentation By Service Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
• 17.3 Rest of the World (ROW) Preclinical CRO Services Market, Segmentation By Animal Model, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
• 17.4 Rest of the World (ROW) Preclinical CRO Services Market, Segmentation By Assay Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
• 17.5 Rest of the World (ROW) Preclinical CRO Services Market, Segmentation By Disease Area, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)

18 Competitive Landscape And Company Profiles

• 18.1 Company Profiles
• 18.2 Charles River Laboratories International Inc
  • 18.2.1 Company Overview
  • 18.2.2 Products And Services
  • 18.2.3 Business Strategy
  • 18.2.4 Financial Overview
• 18.3 Wuxi AppTec Co. Ltd
  • 18.3.1 Company Overview
  • 18.3.2 Products And Services
  • 18.3.3 Business Strategy
  • 18.3.4 Financial Overview
• 18.4 Eurofins Scientific SE
  • 18.4.1 Company Overview
  • 18.4.2 Products And Services
  • 18.4.3 Business Strategy
  • 18.4.4 Financial Overview
• 18.5 Pharmaron Beijing Co Ltd
  • 18.5.1 Company Overview
  • 18.5.2 Products And Services
  • 18.5.3 Financial Overview
• 18.6 Aragen Life Sciences
  • 18.6.1 Company Overview
  • 18.6.2 Products And Services
  • 18.6.3 Financial Overview

19 Other Major And Innovative Companies

• 19.1 Altasciences Inc.
  • 19.1.1 Company Overview
  • 19.1.2 Products And Services
• 19.2 QPS Holdings LLC
  • 19.2.1 Company Overview
  • 19.2.2 Products And Services
• 19.3 Jubilant Biosys Ltd.
  • 19.3.1 Company Overview
  • 19.3.2 Products And Services
• 19.4 Veranex
  • 19.4.1 Company Overview
  • 19.4.2 Products And Services
• 19.5 Kunming Biomed International Ltd.
  • 19.5.1 Company Overview
  • 19.5.2 Products And Services

20 Competitive Benchmarking

21 Competitive Dashboard

22 Key Mergers And Acquisitions

• 22.1 Symeres B.V. Acquired DGr Pharma
• 22.2 PharmaLegacy Laboratories Acquired BTS Research

23 Recent Development In Preclinical CRO Services

• 23.1 End-To-End Preclinical Platform Accelerating Radiopharmaceutical Translation
• 23.2 Integrated Innovation-Driven Research Model Accelerating MedTech Development

24 Opportunities And Strategies

• 24.1 Global Preclinical CRO Services Market In 2030 - Countries Offering Most New Opportunities
• 24.2 Global Preclinical CRO Services Market In 2030 - Segments Offering Most New Opportunities
• 24.3 Global Preclinical CRO Services Market In 2030 - Growth Strategies
  • 24.3.1 Market Trend Based Strategies
  • 24.3.2 Competitor Strategies

25 Preclinical CRO Services Market, Conclusions And Recommendations

• 25.1 Conclusions
• 25.2 Recommendations
  • 25.2.1 Product
  • 25.2.2 Place
  • 25.2.3 Price
  • 25.2.4 Promotion
  • 25.2.5 People

26 Appendix

• 26.1 Geographies Covered
• 26.2 Market Data Sources
• 26.3 Research Methodology
• 26.4 Currencies
• 26.5 The Business Research Company
• 26.6 Copyright and Disclaimer